Company Filing History:
Years Active: 2025
Title: Qinqing Peng: Innovator in iPSC Differentiation
Introduction
Qinqing Peng is a notable inventor based in Beijing, China. He has made significant contributions to the field of stem cell research, particularly in the differentiation of induced pluripotent stem cells (iPSCs). His innovative work has the potential to advance medical treatments and therapies.
Latest Patents
Qinqing Peng holds a patent for a culture medium and method for inducing iPSC differentiation to obtain macrophages. This patent, which is a crucial advancement in stem cell technology, outlines a medium combination that includes a first stage medium to a sixth stage medium. The first stage medium is an E8 complete medium containing a ROCK pathway inhibitor and polyvinyl alcohol. The subsequent stages involve various combinations of E8 complete medium and specific inhibitors, ultimately leading to the successful differentiation of iPSCs into macrophages.
Career Highlights
Qinqing Peng is associated with Allife Medicine (Beijing) Limited, where he applies his expertise in stem cell research. His work is instrumental in developing new methodologies that can enhance the understanding and application of iPSCs in regenerative medicine.
Collaborations
He collaborates with esteemed colleagues such as Shixin Gong and Yuchun Gu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Qinqing Peng's contributions to the field of stem cell research, particularly through his patent on iPSC differentiation, highlight his role as a leading inventor in this vital area of medical science. His work continues to pave the way for future advancements in regenerative medicine.